Publication | Open Access
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
49
Citations
31
References
2022
Year
Scalp biomarkers provide evidence of dupilumab efficacy in AA, detected even prior to clinical response, with exclusive correlations between early suppression of Th2 markers and increased hair keratins. These findings strengthen previous reports suggesting a possible role for Th2 cytokines as AA drivers.
| Year | Citations | |
|---|---|---|
2012 | 53.2K | |
2013 | 27.4K | |
2016 | 9.5K | |
2014 | 6.4K | |
2014 | 916 | |
2018 | 647 | |
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities Mayte Suárez‐Fariñas, Suzanne J. Tintle, Avner Shemer, Journal of Allergy and Clinical Immunology Atopic DermatitisImmunologySkin AllergyVariable Immune AbnormalitiesContact Dermatitis | 2011 | 452 |
2014 | 284 | |
2015 | 246 | |
2009 | 214 |
Page 1
Page 1